[Metharmon F for glossalgia caused by autonomic dysfunction].
D000328:Adult; D000368:Aged; D015114:Androstenediol / Q000627:therapeutic use*; D000734:Androstenediols / Q000627:therapeutic use*; D000735:Androstenedione / Q000627:therapeutic use*; D001342:Autonomic Nervous System Diseases / Q000150:complications*; D004338:Drug Combinations / Q000627:therapeutic use; D004970:Estrone / Q000627:therapeutic use*; D005260:Female; D005926:Glossalgia / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008875:Middle Aged; D011284:Pregnenolone / Q000627:therapeutic use*; D013739:Testosterone / Q000627:therapeutic use*; D013962:Thyroid (USP) / Q000627:therapeutic use*; D013963:Thyroid Hormones / Q000627:therapeutic use*
D000734:Androstenediols; D004338:Drug Combinations; D013962:Thyroid (USP); D013963:Thyroid Hormones; D004970:Estrone; D013739:Testosterone; D000735:Androstenedione; D011284:Pregnenolone; C039452:Metharmon F; D015114:Androstenediol